» Articles » PMID: 23934478

Gastrointestinal Manifestations of Behçet's Disease in Japan: a Study of 43 Patients

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2013 Aug 13
PMID 23934478
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the clinical gastrointestinal (GI) characteristics of Behçet's disease (BD) patients in Japan. We retrospectively reviewed the clinical charts of 412 patients who fulfilled the 1987 Japanese criteria for BD and were treated in two university hospitals from July 1991 to December 2007. Forty-three patients (10.4 %) had BD-related GI lesions, which were shown by imaging examinations. Median age at BD diagnosis and onset of GI episodes were 29.6 and 31.0 years, respectively. The patients suffered from abdominal pain (30/43) and GI bleeding (18/43), while they had lower frequency of eye involvement and higher incidence of arthritis and vascular involvement than BD patients without GI lesions. The lesions were prevalent in the ileum (32/43) followed by cecum (21/43) and esophagus (9/43). The patients were treated with mesalazine and sulfasalazine (41/43), corticosteroids (32/43), immunosuppressants (13/43), and infliximab for 7 patients having refractory lesions, while 10 patients had surgical operation. Two patients died due to non-GI events during the observation. The diagnosis of BD was often difficult because of lack of eye involvement. Surgery is required for some patients in spite of intensive immunosuppressive therapies. Appropriate use of anti-TNF agents may be promising for the GI involvement.

Citing Articles

Possible Association of Mutations in the Gene with the Intestinal Phenotype of Behçet's Disease and Refractoriness to Treatment.

Furuta Y, Gushima R, Naoe H, Honda M, Tsuruta Y, Nagaoka K J Clin Med. 2023; 12(9).

PMID: 37176572 PMC: 10179346. DOI: 10.3390/jcm12093131.


Perianal ulcers without genital ulcers: a rare presentation of Behçet's disease.

Seiki S, Matsuura Y, Terada H, Doi Y Rheumatol Adv Pract. 2022; 6(2):rkac047.

PMID: 35734573 PMC: 9204468. DOI: 10.1093/rap/rkac047.


New insight into the features of Behçet's disease with gastrointestinal ulcer: a cross-sectional observational study.

Ye J, Hou C, Bao H, Guan J Orphanet J Rare Dis. 2021; 16(1):444.

PMID: 34674734 PMC: 8532303. DOI: 10.1186/s13023-021-02056-0.


Experimental Therapeutic Solutions for Behcet's Disease.

Bozca B, Alpsoy E J Exp Pharmacol. 2021; 13:127-145.

PMID: 33603502 PMC: 7886245. DOI: 10.2147/JEP.S265645.


Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Soejima Y, Kirino Y, Takeno M, Kurosawa M, Takeuchi M, Yoshimi R Arthritis Res Ther. 2021; 23(1):49.

PMID: 33522943 PMC: 7851921. DOI: 10.1186/s13075-020-02406-6.


References
1.
Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y . Behçet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011; 90(2):125-132. DOI: 10.1097/MD.0b013e318211bf28. View

2.
Choi I, Kim J, Cha S, Jung H, Park J, Song I . Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum. 2000; 43(5):692-700. DOI: 10.1007/BF02235590. View

3.
Bang D, Lee J, Lee E, Lee S, Choi J, Kim Y . Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study. J Korean Med Sci. 2001; 16(5):615-8. PMC: 3057606. DOI: 10.3346/jkms.2001.16.5.615. View

4.
Sakane T, Takeno M, Suzuki N, Inaba G . Behçet's disease. N Engl J Med. 1999; 341(17):1284-91. DOI: 10.1056/NEJM199910213411707. View

5.
Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Yalcin B, Muftuoglu A . Behçet's disease as seen in Turkey. Haematologica. 1980; 65(3):381-3. View